About this trial
RE-LAM-CE is a registry of lymphangioleiomyomatosis cases in France. its aim is to determine the incidence and prevalence of lymphangioleiomyomatosis in France, including demographic information and information concerning the timing and modalities of diagnosis.
Based on the registry, we will set up a prospective cohort of patients. The database will include detailed medical information, particularly regarding progression of the respiratory function.
Eligibility criteria
Qualifiers
Patients with sporadic lymphangioleiomyomatosis or associated with Tuberous sclerosis.
patients diagnosed or hospitalized or seen in consultation since 01/01/2008
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Vincent COTTIN
Lead sponsor
Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires
Sponsor institution
Hospices Civils de Lyon
Collaborator